HOME › DRUGS › CETUXIMAB
ACTIVE SUBSTANCE / INN

CETUXIMAB

Brand name(s): ERBITUX, Erbitux
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Head and Neck Neoplasms;Colorectal Neoplasms
BLA125084
ACTIVE SUBSTANCE
Cetuximab
REGULATORS
FDA · EMA
SPONSORS / MAH
IMCLONE, Merck Europe B.V. 
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ERBITUXBLA125084IMCLONEPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ErbituxMerck Europe B.V. Authorised29/06/2004Head and Neck Neoplasms;Colorectal Neoplasms

FULL INTELLIGENCE ON CETUXIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →